Deborah J E Marriott
Overview
Explore the profile of Deborah J E Marriott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stojanova J, Brown J, Reuter S, Marriott D
Int J Antimicrob Agents
. 2024 Apr;
63(6):107170.
PMID: 38604388
No abstract available.
2.
Carland J, Stojanova J, Lau C, Day R, Marriott D
Ther Drug Monit
. 2024 Feb;
46(3):415-416.
PMID: 38321597
No abstract available.
3.
Robosa R, Lau C, Stojanova J, Chin C, Marriott D
Ther Drug Monit
. 2023 Jul;
45(6):711-713.
PMID: 37448154
Ceftazidime-avibactam (CTZ-AVM) is a novel cephalosporin/beta-lactamase inhibitor with broad-spectrum activity against multidrug-resistant Pseudomonas aeruginosa . Ceftazidime-induced neurotoxicity is a well-described adverse effect, particularly in patients with renal insufficiency. However, appropriate...
4.
Burrows F, Carlos L, Stojanova J, Marriott D
Int J Antimicrob Agents
. 2023 Jun;
62(3):106908.
PMID: 37385563
Aim: Tacrolimus is a CYP3A4 substrate with a narrow therapeutic index that requires dose adjustment when used with voriconazole, a recognized CYP3A4 inhibitor. Interactions involving flucloxacillin and tacrolimus or voriconazole...
5.
Marriott D, Cattaneo D
Ther Drug Monit
. 2023 Mar;
45(2):209-216.
PMID: 36920503
No abstract available.
6.
Seah V, Sreeharan T, Kocic D, Reuter S, Girgis L, Marriott D, et al.
Ther Drug Monit
. 2023 Feb;
45(2):129-132.
PMID: 36730858
The authors present the case of a 34-year-old male patient who underwent therapeutic plasma exchange (TPE) for amyopathic dermatomyositis. Immunosuppression resulted in Aspergillus lentulus pulmonary infection , requiring treatment with...
7.
Margineanu I, Akkerman O, Cattaneo D, Goletti D, Marriott D, Migliori G, et al.
Eur Respir J
. 2022 Jan;
59(4).
PMID: 35086830
No abstract available.
8.
Chau M, Daveson K, Alffenaar J, Gwee A, Ho S, Marriott D, et al.
Intern Med J
. 2021 Dec;
51 Suppl 7:37-66.
PMID: 34937141
Antifungal agents can have complex dosing and the potential for drug interaction, both of which can lead to subtherapeutic antifungal drug concentrations and poorer clinical outcomes for patients with haematological...
9.
10.
Reuter S, Stocker S, Alffenaar J, Baldelli S, Cattaneo D, Jones G, et al.
Ther Drug Monit
. 2021 Dec;
44(1):121-132.
PMID: 34882107
Individualization of vancomycin dosing based on therapeutic drug monitoring (TDM) data is known to improve patient outcomes compared with fixed or empirical dosing strategies. There is increasing evidence to support...